More than half with hemophilia had gaps in prescribed factor treatment

This gap between "prescription and practice" was evident even though Brazil provides universal, free access to clotting factor concentrates through […]

More than half with hemophilia had gaps in prescribed factor treatment

Share this story

Send the public story page.

Useful takeaways from this story.

This gap between "prescription and practice" was evident even though Brazil provides universal, free access to clotting factor concentrates through […]

More than half of people with hemophilia receiving prophylactic (preventive) factor replacement therapies at two treatment centers in Brazil did not collect enough medication to follow their prescribed...

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

This gap between "prescription and practice" was evident even though Brazil provides universal, free access to clotting factor concentrates through […] More than half of people with hemophilia receiving prophylactic (preventive) factor replacement therapies at two treatment centers in Brazil did not collect enough medication to follow their prescribed treatment regimen, a real-world study has found.

How it works

  • More than half of people with hemophilia receiving prophylactic (preventive) factor replacement therapies at two treatment centers in Brazil did not collect enough medication to follow their prescribed...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app